{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:00:36Z","timestamp":1778655636556,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T00:00:00Z","timestamp":1478304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00540-016-2278-y","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T05:34:34Z","timestamp":1478324074000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of dexmedetomidine effects on left ventricular function using pressure\u2013volume loops in rats"],"prefix":"10.1007","volume":"31","author":[{"given":"Kyuho","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jeong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ok Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,5]]},"reference":[{"key":"2278_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(88)90744-3","volume":"150","author":"R Virtanen","year":"1988","unstructured":"Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:9\u201314.","journal-title":"Eur J Pharmacol"},{"key":"2278_CR2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.aco.0000174958.05383.d5","volume":"18","author":"A Paris","year":"2005","unstructured":"Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol. 2005;18:412\u20138.","journal-title":"Curr Opin Anaesthesiol"},{"key":"2278_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/bja\/aen320","volume":"102","author":"TF Lin","year":"2009","unstructured":"Lin TF, Yeh YC, Lin FS, Wang YP, Lin CJ, Sun WZ, Fan SZ. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anaesth. 2009;102:117\u201322.","journal-title":"Br J Anaesth"},{"issue":"Suppl 12","key":"2278_CR4","first-page":"S128","volume":"10","author":"L Quintin","year":"1987","unstructured":"Quintin L, Ghignone M, Pujol JF. The ability of the alpha 2-adrenergic agonist clonidine to suppress central noradrenergic hyperactivity secondary to hemodynamic or environmental stimuli. J Cardiovasc Pharmacol. 1987;10(Suppl 12):S128\u201334.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2278_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/clpt.1989.103","volume":"46","author":"A Kallio","year":"1989","unstructured":"Kallio A, Scheinin M, Koulu M, Ponkilainen R, Ruskoaho H, Viinamaki O, Scheinin H. Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther. 1989;46:33\u201342.","journal-title":"Clin Pharmacol Ther"},{"key":"2278_CR6","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00000542-200403000-00040","volume":"100","author":"E Ingersoll-Weng","year":"2004","unstructured":"Ingersoll-Weng E, Manecke GR Jr, Thistlethwaite PA. Dexmedetomidine and cardiac arrest. Anesthesiology. 2004;100:738\u20139.","journal-title":"Anesthesiology"},{"key":"2278_CR7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1213\/ane.0b013e318172fafc","volume":"106","author":"TC Sichrovsky","year":"2008","unstructured":"Sichrovsky TC, Mittal S, Steinberg JS. Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg. 2008;106:1784\u20136.","journal-title":"Anesth Analg"},{"key":"2278_CR8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/0019-5049.160965","volume":"59","author":"CN Jaideep","year":"2015","unstructured":"Jaideep CN, Bhargava DV. Good vagal tone, a tourniquet and dexmedetomidine: recipe for disaster. Indian J Anaesth. 2015;59:450\u20131.","journal-title":"Indian J Anaesth"},{"key":"2278_CR9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/anae.13084","volume":"70","author":"SH Lee","year":"2015","unstructured":"Lee SH, Choi YS, Hong GR, Oh YJ. Echocardiographic evaluation of the effects of dexmedetomidine on cardiac function during total intravenous anaesthesia. Anaesthesia. 2015;70:1052\u20139.","journal-title":"Anaesthesia"},{"key":"2278_CR10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/1053-0770(92)90006-S","volume":"6","author":"WE Flacke","year":"1992","unstructured":"Flacke WE, Flacke JW, Blow KD, McIntee DF, Bloor BC. Effect of dexmedetomidine, an alpha 2-adrenergic agonist, in the isolated heart. J Cardiothorac Vasc Anesth. 1992;6:418\u201323.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2278_CR11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00000542-199109000-00018","volume":"75","author":"WT Schmeling","year":"1991","unstructured":"Schmeling WT, Kampine JP, Roerig DL, Warltier DC. The effects of the stereoisomers of the alpha 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology. 1991;75:499\u2013511.","journal-title":"Anesthesiology"},{"key":"2278_CR12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00005344-199010000-00013","volume":"16","author":"JW Flacke","year":"1990","unstructured":"Flacke JW, Flacke WE, Bloor BC, McIntee DF. Hemodynamic effects of dexmedetomidine, an alpha 2-adrenergic agonist, in autonomically denervated dogs. J Cardiovasc Pharmacol. 1990;16:616\u201323.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2278_CR13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.echo.2003.10.010","volume":"17","author":"LE Watson","year":"2004","unstructured":"Watson LE, Sheth M, Denyer RF, Dostal DE. Baseline echocardiographic values for adult male rats. J Am Soc Echocardiogr. 2004;17:161\u20137.","journal-title":"J Am Soc Echocardiogr"},{"key":"2278_CR14","doi-asserted-by":"crossref","first-page":"H501","DOI":"10.1152\/ajpheart.00138.2005","volume":"289","author":"D Burkhoff","year":"2005","unstructured":"Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure\u2013volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005;289:H501\u201312.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2278_CR15","first-page":"H1416","volume":"274","author":"D Georgakopoulos","year":"1998","unstructured":"Georgakopoulos D, Mitzner WA, Chen CH, Byrne BJ, Millar HD, Hare JM, Kass DA. In vivo murine left ventricular pressure\u2013volume relations by miniaturized conductance micromanometry. Am J Physiol. 1998;274:H1416\u201322.","journal-title":"Am J Physiol"},{"key":"2278_CR16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3346\/jkms.2012.27.11.1411","volume":"27","author":"HJ Park","year":"2012","unstructured":"Park HJ, Kim YH, Koh HJ, Park CS, Kang SH, Choi JH, Moon DE. Analgesic effects of dexmedetomidine in vincristine-evoked painful neuropathic rats. J Korean Med Sci. 2012;27:1411\u20137.","journal-title":"J Korean Med Sci"},{"key":"2278_CR17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.5665\/sleep.3650","volume":"37","author":"WA Filbey","year":"2014","unstructured":"Filbey WA, Sanford DT, Baghdoyan HA, Koch LG, Britton SL, Lydic R. Eszopiclone and dexmedetomidine depress ventilation in obese rats with features of metabolic syndrome. Sleep. 2014;37:871\u201380.","journal-title":"Sleep"},{"key":"2278_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(24)35083-9","volume":"291","author":"CJ Bol","year":"1999","unstructured":"Bol CJ, Vogelaar JP, Mandema JW. Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats. J Pharmacol Exp Ther. 1999;291:153\u201360.","journal-title":"J Pharmacol Exp Ther"},{"key":"2278_CR19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659\u201361.","journal-title":"FASEB J"},{"key":"2278_CR20","doi-asserted-by":"crossref","unstructured":"Hammer GB, Drover DR, Cao H, Jackson E, Williams GD, Ramamoorthy C, Van Hare GF, Niksch A, Dubin AM. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg. 2008;106:79\u201383 (table of contents).","DOI":"10.1213\/01.ane.0000297421.92857.4e"},{"key":"2278_CR21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/0976-9668.127323","volume":"5","author":"S Singh","year":"2014","unstructured":"Singh S, Singh A. Dexmedetomidine induced catecholamine suppression in pheochromocytoma. J Nat Sci Biol Med. 2014;5:182\u20133.","journal-title":"J Nat Sci Biol Med"},{"key":"2278_CR22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00000542-199011000-00020","volume":"73","author":"PR Housmans","year":"1990","unstructured":"Housmans PR. Effects of dexmedetomidine on contractility, relaxation, and intracellular calcium transients of isolated ventricular myocardium. Anesthesiology. 1990;73:919\u201322.","journal-title":"Anesthesiology"},{"key":"2278_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/1053-0770(93)90117-4","volume":"7","author":"WE Flacke","year":"1993","unstructured":"Flacke WE, Flacke JW, Bloor BC, McIntee DF, Sagan M. Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiothorac Vasc Anesth. 1993;7:41\u20139.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2278_CR24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.CIR.79.1.167","volume":"79","author":"DA Kass","year":"1989","unstructured":"Kass DA, Beyar R, Lankford E, Heard M, Maughan WL, Sagawa K. Influence of contractile state on curvilinearity of in situ end-systolic pressure\u2013volume relations. Circulation. 1989;79:167\u201378.","journal-title":"Circulation"},{"key":"2278_CR25","doi-asserted-by":"crossref","first-page":"e2805","DOI":"10.1097\/MD.0000000000002805","volume":"95","author":"SH Lee","year":"2016","unstructured":"Lee SH, Na S, Kim N, Ban MG, Shin SE, Oh YJ. The effects of dexmedetomidine on myocardial function assessed by tissue doppler echocardiography during general anesthesia in patients with diastolic dysfunction: a CONSORT-prospective, randomized, controlled trial. Medicine (Baltimore). 2016;95:e2805.","journal-title":"Medicine (Baltimore)"},{"key":"2278_CR26","doi-asserted-by":"crossref","first-page":"R287","DOI":"10.1152\/ajpregu.00123.2002","volume":"283","author":"M Philipp","year":"2002","unstructured":"Philipp M, Brede M, Hein L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol. 2002;283:R287\u201395.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2278_CR27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00540-006-0487-5","volume":"21","author":"T Akata","year":"2007","unstructured":"Akata T. Cellular and molecular mechanisms regulating vascular tone. Part 1: basic mechanisms controlling cytosolic Ca2+\u00a0concentration and the Ca2+-dependent regulation of vascular tone. J Anesth. 2007;21:220\u201331.","journal-title":"J Anesth"},{"key":"2278_CR28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00540-006-0488-4","volume":"21","author":"T Akata","year":"2007","unstructured":"Akata T. Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+\u00a0mobilization and\/or myofilament Ca2+\u00a0sensitivity in vascular smooth muscle cells. J Anesth. 2007;21:232\u201342.","journal-title":"J Anesth"},{"key":"2278_CR29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.bjp.0704320","volume":"134","author":"XF Figueroa","year":"2001","unstructured":"Figueroa XF, Poblete MI, Boric MP, Mendizabal VE, Adler-Graschinsky E, Huidobro-Toro JP. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. Br J Pharmacol. 2001;134:957\u201368.","journal-title":"Br J Pharmacol"},{"key":"2278_CR30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1124\/jpet.110.170688","volume":"335","author":"ES Wong","year":"2010","unstructured":"Wong ES, Man RY, Vanhoutte PM, Ng KF. Dexmedetomidine induces both relaxations and contractions, via different {alpha}2-adrenoceptor subtypes, in the isolated mesenteric artery and aorta of the rat. J Pharmacol Exp Ther. 2010;335:659\u201364.","journal-title":"J Pharmacol Exp Ther"},{"key":"2278_CR31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0165-1838(98)00061-7","volume":"71","author":"H Xu","year":"1998","unstructured":"Xu H, Aibiki M, Seki K, Ogura S, Ogli K. Effects of dexmedetomidine, an alpha2-adrenoceptor agonist, on renal sympathetic nerve activity, blood pressure, heart rate and central venous pressure in urethane-anesthetized rabbits. J Auton Nerv Syst. 1998;71:48\u201354.","journal-title":"J Auton Nerv Syst"},{"key":"2278_CR32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1139\/y04-028","volume":"82","author":"J Penttila","year":"2004","unstructured":"Penttila J, Helminen A, Anttila M, Hinkka S, Scheinin H. Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects. Can J Physiol Pharmacol. 2004;82:359\u201362.","journal-title":"Can J Physiol Pharmacol"},{"key":"2278_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neulet.2015.04.035","volume":"597","author":"K Tsuzawa","year":"2015","unstructured":"Tsuzawa K, Minoura Y, Takeda S, Inagaki K, Onimaru H. Effects of alpha2-adorenoceptor agonist dexmedetomidine on respiratory rhythm generation of newborn rats. Neurosci Lett. 2015;597:117\u201320.","journal-title":"Neurosci Lett"},{"key":"2278_CR34","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00000542-199005000-00019","volume":"72","author":"SR Furst","year":"1990","unstructured":"Furst SR, Weinger MB. Dexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat. Anesthesiology. 1990;72:882\u20138.","journal-title":"Anesthesiology"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-016-2278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-016-2278-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-016-2278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:47:56Z","timestamp":1749689276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-016-2278-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2278"],"URL":"https:\/\/doi.org\/10.1007\/s00540-016-2278-y","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,5]]}}}